{"Symbol": "DGX", "AssetType": "Common Stock", "Name": "Quest Diagnostics Incorporated", "Description": "Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.", "CIK": "1022079", "Exchange": "NYSE", "Currency": "USD", "Country": "USA", "Sector": "LIFE SCIENCES", "Industry": "SERVICES-MEDICAL LABORATORIES", "Address": "500 PLAZA DRIVE, SECAUCUS, NJ, US", "OfficialSite": "https://www.questdiagnostics.com", "FiscalYearEnd": "December", "LatestQuarter": "2024-12-31", "MarketCapitalization": "19354278000", "EBITDA": "1903000000", "PERatio": "21.82", "PEGRatio": "1.465", "BookValue": "61.06", "DividendPerShare": "0", "DividendYield": "0.0198", "EPS": "7.92", "RevenuePerShareTTM": "88.94", "ProfitMargin": "0.0882", "OperatingMarginTTM": "0.14", "ReturnOnAssetsTTM": "0.0584", "ReturnOnEquityTTM": "0.138", "RevenueTTM": "9872000000", "GrossProfitTTM": "3271000000", "DilutedEPSTTM": "7.92", "QuarterlyEarningsGrowthYOY": "0.202", "QuarterlyRevenueGrowthYOY": "0.146", "AnalystTargetPrice": "180.74", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "7", "AnalystRatingHold": "10", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "21.82", "ForwardPE": "16.69", "PriceToSalesRatioTTM": "1.96", "PriceToBookRatio": "2.65", "EVToRevenue": "2.482", "EVToEBITDA": "12.94", "Beta": "0.776", "52WeekHigh": "178.0", "52WeekLow": "131.39", "50DayMovingAverage": "168.61", "200DayMovingAverage": "157.04", "SharesOutstanding": "111978000", "DividendDate": "2025-04-21", "ExDividendDate": "2025-04-07"}